Upstream tumor suppressors, including MST1, LATS1/2, and FAT1/2/3/4, frequently undergo deletions or mutations, whereas downstream oncogenes such as YAP1, WWTR1, and TEAD1/2/3/4 are upregulated (72). Here, MST1 is linked to neoplasm.